Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract

  title={Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract},
  author={Vesarat Wessagowit and Chinmanat Tangjaturonrusamee and Tanawatt Kootiratrakarn and Thareena Bunnag and Tanatya Pimonrat and Nattaporn Muangdang and Pitchayasak Pichai},
  journal={Australasian Journal of Dermatology},
BACKGROUND/OBJECTIVES Male androgenetic alopecia (AGA) is a common hair problem. [] Key MethodMETHODS This was a pilot, prospective, open, within-subject comparison limited to 24 weeks using no placebo controls. In all, 50 male volunteers aged between 20 and 50 years received topical S. repens products for 24 weeks. The primary end-point was a hair count in an area of 2.54 cm(2) at week 24.

Natural products for male androgenetic alopecia

The selected clinical studies suggest that saw palmetto, caffeine, melatonin, marine extracts, rosemary oil, procyanidin, pumpkin seed oil, and cannabidiol oil might be considered in male AGA treatment.

Alternative Medicine for Hair Loss

Although there are little randomized-controlled studies investigating the effectiveness in the treatment of hair loss, reported results have demonstrated that complementary and alternative medicine will become much more popular in the near future.

A Comprehensive Review of Natural Alternatives for Treatment of Alopecia with an Overview of Market Products.

This study presents a review of reported herbal remedies and herb combinations recommended for hair loss and their mode of action, along with an overview of available market products and formulations, their composition, and declared effects.

Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia

Although robust high-quality data are lacking, supplements containing SP may be a treatment option for patients with androgenetic alopecia, telogen effluvium, and self-perceived hair thinning.

Efficacy of phytotherapy in the treatment of androgenetic alopecia

The researches showed results with a positive effect of the use of this treatment on the hair growth of the individuals studied, with better resistance and increase of hair of the anagen phase.


It was experimentally substantiated the optimal ratio of the emulgel ingredients that provide good APIs release and necessary consumer properties of the semi-solid remedy like application compliance, safety and storage stability.

Complementary and Alternative Treatments for Alopecia: A Comprehensive Review

A comprehensive review of the efficacy, safety, and tolerability of CAM, including natural products and mind and body practices, in the treatment of hair loss suggests there is a need for additional studies investigating CAM for alopecia with more robust clinical design and standardized, quantitative outcomes.

The efficacy of topical minoxidil 2% versus topical botanically derived inhibitors of 5 alpha reductase in treatment of female pattern hair loss by trichoscopy

Minoxidil is recommended as a first line of therapy for patients with FPHL who want a treatment with affordable price and could tolerate its side effects, and it is advised to shift to topical botanical 5αRIs as a second line therapy, in cases that were nontolerant to minxidil due to its fewer side effects.

A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review

A widespread review of topical marketed formulations, natural products, and CAM treatment options for Androgenic alopecia is offered.

A Scoping Review of Pharmacotherapy, Complementary, and Alternative Medicine (CAM), and Surgical Therapies for Androgenic Alopecia

Alternative and complementary treatment options for AGA have increased in pharmacotherapeutics, surgical, and complementary (CAM) categories and awareness of the current evidence supporting complementary and alternative therapies among dermatologists will facilitate appropriate and timely education of AGA patients.

Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men

Androgenetic alopecia is the most common hair loss disorder, affecting both men and women and its frequency increases with age and affects up to 80 % Caucasian men and 42 % of women.

Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.

It is observed that Serenoa repens could lead to an improvement of androgenetic alopecia, while finasteride confirmed its efficacy.

Comparitive Effectiveness and Finasteride Vs Serenoa Repens in Male Androgenetic Alopecia: A Two-Year Study

It is observed that Serenoa repens could lead to an improvement of androgenetic alopecia, while finasteride confirmed its efficacy.

Effects of long‐term treatment with Serenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia

The response of testosterone (T), dihydrotestosterone (DHT), and epidermal growth factor (EGF) in BPH tissue of patients treated with LSESr (320 mg/day for 3 months) is analyzed.

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents

This S1 guideline for diagnostic evaluation of AGA in men, women and adolescents reviews the definition of AGA and presents expert opinion‐based recommendations for sex‐dependent steps in the diagnostic procedure.

Use of Low-Level Laser Therapy as Monotherapy or Concomitant Therapy for Male and Female Androgenetic Alopecia

LLLT represents a potentially effective treatment for both male and female AGA, either as monotherapy or concomitant therapy, and combination treatments with minoxidil, finasteride, and LLLT may act synergistic to enhance hair growth.

Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.

In men with male pattern hair loss, finasteride 1 mg daily slowed the progression of hair loss and increased hair growth in clinical trials over two years.

Serenoa repens for benign prostatic hyperplasia.

The main outcome measure for comparing the effectiveness of Serenoa repens with placebo or other interventions was the change in urologic symptom-scale scores, and secondary outcomes included changes in nocturia and urodynamic measures.